Jorge António Ribeiro Salvador
AuthID: R-000-7NJ
11
TITLE: Deep generative model for therapeutic targets using transcriptomic disease-associated data-USP7 case study Full Text
AUTHORS: Pereira, Tiago; Abbasi, Maryam; Oliveira, Rita, I; Guedes, Romina A.; Salvador, Jorge A. R.; Arrais, Joel P.;
PUBLISHED: 2022, SOURCE: BRIEFINGS IN BIOINFORMATICS, VOLUME: 23, ISSUE: 4
AUTHORS: Pereira, Tiago; Abbasi, Maryam; Oliveira, Rita, I; Guedes, Romina A.; Salvador, Jorge A. R.; Arrais, Joel P.;
PUBLISHED: 2022, SOURCE: BRIEFINGS IN BIOINFORMATICS, VOLUME: 23, ISSUE: 4
INDEXED IN: Scopus WOS
12
TITLE: Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment
AUTHORS: Rita C Acúrcio; Sabina Pozzi; Barbara Carreira; Marta Pojo; Nuria Gómez Cebrián; Sandra Casimiro; Adelaide Fernandes; Andreia Barateiro; Vitor Farricha; Joaquim Brito; Ana Paula Leandro; Jorge A R Salvador; Luís Graça; Leonor Puchades Carrasco; Luís Costa; Ronit Satchi Fainaro; Rita C Guedes; Helena F Florindo;
PUBLISHED: 2022, SOURCE: Journal for immunotherapy of cancer, VOLUME: 10, ISSUE: 7
AUTHORS: Rita C Acúrcio; Sabina Pozzi; Barbara Carreira; Marta Pojo; Nuria Gómez Cebrián; Sandra Casimiro; Adelaide Fernandes; Andreia Barateiro; Vitor Farricha; Joaquim Brito; Ana Paula Leandro; Jorge A R Salvador; Luís Graça; Leonor Puchades Carrasco; Luís Costa; Ronit Satchi Fainaro; Rita C Guedes; Helena F Florindo;
PUBLISHED: 2022, SOURCE: Journal for immunotherapy of cancer, VOLUME: 10, ISSUE: 7
INDEXED IN: Scopus
13
TITLE: Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment
AUTHORS: Acurcio, Rita C.; Pozzi, Sabina; Carreira, Barbara; Pojo, Marta; Gomez Cebrian, Nuria; Casimiro, Sandra; Fernandes, Adelaide; Barateiro, Andreia; Farricha, Vitor; Brito, Joaquim; Leandro, Ana Paula; Salvador, Jorge A. R.; Graca, Luis; Puchades Carrasco, Leonor; Costa, Luis; Satchi Fainaro, Ronit; Guedes, Rita C.; Florindo, Helena F.;
PUBLISHED: 2022, SOURCE: JOURNAL FOR IMMUNOTHERAPY OF CANCER, VOLUME: 10, ISSUE: 7
AUTHORS: Acurcio, Rita C.; Pozzi, Sabina; Carreira, Barbara; Pojo, Marta; Gomez Cebrian, Nuria; Casimiro, Sandra; Fernandes, Adelaide; Barateiro, Andreia; Farricha, Vitor; Brito, Joaquim; Leandro, Ana Paula; Salvador, Jorge A. R.; Graca, Luis; Puchades Carrasco, Leonor; Costa, Luis; Satchi Fainaro, Ronit; Guedes, Rita C.; Florindo, Helena F.;
PUBLISHED: 2022, SOURCE: JOURNAL FOR IMMUNOTHERAPY OF CANCER, VOLUME: 10, ISSUE: 7
INDEXED IN: WOS
14
TITLE: Deep generative model for therapeutic targets using transcriptomic disease-associated data - USP7 case study
AUTHORS: Tiago Pereira; Maryam Abbasi; Rita I Oliveira; Romina A Guedes; Jorge A R Salvador; Joel P Arrais;
PUBLISHED: 2022, SOURCE: Briefings Bioinform., VOLUME: 23, ISSUE: 4
AUTHORS: Tiago Pereira; Maryam Abbasi; Rita I Oliveira; Romina A Guedes; Jorge A R Salvador; Joel P Arrais;
PUBLISHED: 2022, SOURCE: Briefings Bioinform., VOLUME: 23, ISSUE: 4
INDEXED IN: DBLP
15
TITLE: Highlights in USP7 inhibitors for cancer treatment
AUTHORS: Oliveira, Rita I.; Guedes, Romina A.; Salvador, Jorge A. R.;
PUBLISHED: 2022, SOURCE: FRONTIERS IN CHEMISTRY, VOLUME: 10
AUTHORS: Oliveira, Rita I.; Guedes, Romina A.; Salvador, Jorge A. R.;
PUBLISHED: 2022, SOURCE: FRONTIERS IN CHEMISTRY, VOLUME: 10
INDEXED IN: Scopus WOS
16
TITLE: MDM2-Based Proteolysis-Targeting Chimeras (PROTACs): An Innovative Drug Strategy for Cancer Treatment Full Text
AUTHORS: Vicente, Andre T. S.; Salvador, Jorge A. R.;
PUBLISHED: 2022, SOURCE: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, VOLUME: 23, ISSUE: 19
AUTHORS: Vicente, Andre T. S.; Salvador, Jorge A. R.;
PUBLISHED: 2022, SOURCE: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, VOLUME: 23, ISSUE: 19
INDEXED IN: Scopus WOS
17
TITLE: Design, synthesis, and biological evaluation of new arjunolic acid derivatives as anticancer agents
AUTHORS: Gonçalves, BMF; Mendes, VIS; Silvestre, SM; Salvador, JAR;
PUBLISHED: 2022, SOURCE: RSC Medicinal Chemistry
AUTHORS: Gonçalves, BMF; Mendes, VIS; Silvestre, SM; Salvador, JAR;
PUBLISHED: 2022, SOURCE: RSC Medicinal Chemistry
INDEXED IN: Scopus
18
TITLE: Editorial: Head & Neck Cancer and Esophageal Cancer: From Biosignatures to Therapeutics Full Text
AUTHORS: Kok, VC; Yu, CC; Salvador, JAR;
PUBLISHED: 2021, SOURCE: FRONTIERS IN ONCOLOGY, VOLUME: 11
AUTHORS: Kok, VC; Yu, CC; Salvador, JAR;
PUBLISHED: 2021, SOURCE: FRONTIERS IN ONCOLOGY, VOLUME: 11
INDEXED IN: Scopus WOS
19
TITLE: A patent review of glutaminyl cyclase inhibitors (2004-present)
AUTHORS: Coimbra, JRM; Salvador, JAR;
PUBLISHED: 2021, SOURCE: EXPERT OPINION ON THERAPEUTIC PATENTS
AUTHORS: Coimbra, JRM; Salvador, JAR;
PUBLISHED: 2021, SOURCE: EXPERT OPINION ON THERAPEUTIC PATENTS
INDEXED IN: WOS
20
TITLE: Combining Virtual Screening Protocol and In Vitro Evaluation towards the Discovery of BACE1 Inhibitors Full Text
AUTHORS: Judite R M Coimbra; Salete J Baptista; Teresa C P Dinis; Maria M C Silva; Moreira, PI; Moreira, Paula Isabel; Paula I. Moreira ; Armanda E Santos; Jorge A R Salvador;
PUBLISHED: 2020, SOURCE: BIOMOLECULES, VOLUME: 10, ISSUE: 4
AUTHORS: Judite R M Coimbra; Salete J Baptista; Teresa C P Dinis; Maria M C Silva; Moreira, PI; Moreira, Paula Isabel; Paula I. Moreira ; Armanda E Santos; Jorge A R Salvador;
PUBLISHED: 2020, SOURCE: BIOMOLECULES, VOLUME: 10, ISSUE: 4
INDEXED IN: Scopus WOS